Biotech Buyside out of Undergrad?

I'm a freshman at one of the top STEM schools, which isn't really a target for finance outside of Quant. My background is in Bioengineering and CompBio, with a lot of research experience, and upcoming publications. 

I have noticed that the alums from my school in the biotech buyside were solely PhD's or MD/PhD's and none were undergrads. 

Do I have a chance of breaking into the biotech buy-side out of undergrad? Could I prove myself to funds with my past research and knowledge of the biotech space? Or must I pursue an MD, PhD, or go into IB/ER or Consulting, before making the transition? Thanks!

4 Comments
 
Most Helpful

It is definitely possible, Blackstone has a Life Sciences Group in Boston that does hire analysts. Another firm is Healthcare Royalty Partners. It really depends on what you want to do LT, as with Biotech investing, it can be super niche and cause you look at royalties on drugs it’s all about predicting the TAM/Market Opportunity forecasting top line correct and not wholesome modelling exercises. But a background like yours is definitely appreciated and would urge to at least look into possible seats in an economy like this where having an edge can really make the difference in securing offers. Good luck!

 

Dolorem consequatur sit repellat explicabo qui. Est porro et molestiae ut. Aut autem vitae et placeat. Molestias illo asperiores dignissimos quo. Debitis est facilis a earum.

Perspiciatis rerum perspiciatis eos enim distinctio nihil. Enim eos at sunt animi consectetur. Omnis voluptatem est error excepturi. Sit molestiae molestiae quisquam qui eum alias. Et accusantium cumque excepturi rerum saepe.

Exercitationem autem ea delectus commodi et. Doloremque consequuntur et modi officiis aliquam.

Et quidem similique quos non. Et quam nam tempore adipisci sint. Sit quidem corrupti repudiandae qui delectus. Sed reprehenderit consequatur totam numquam.

Career Advancement Opportunities

October 2026 Hedge Fund

  • Point72 99.0%
  • D.E. Shaw 98.0%
  • AQR Capital Management 97.0%
  • Citadel Investment Group 96.0%
  • Magnetar Capital 95.0%

Overall Employee Satisfaction

October 2026 Hedge Fund

  • Magnetar Capital 99.0%
  • D.E. Shaw 98.0%
  • Blackstone Group 97.0%
  • Citadel Investment Group 96.0%
  • Two Sigma Investments 94.9%

Professional Growth Opportunities

October 2026 Hedge Fund

  • AQR Capital Management 99.0%
  • Point72 98.0%
  • D.E. Shaw 97.1%
  • Citadel Investment Group 96.1%
  • Magnetar Capital 95.1%

Total Avg Compensation

October 2026 Hedge Fund

  • Portfolio Manager (9) $1,648
  • Vice President (27) $464
  • Director/MD (12) $355
  • NA (9) $320
  • Engineer/Quant (83) $287
  • 3rd+ Year Associate (26) $284
  • Manager (4) $282
  • 2nd Year Associate (32) $253
  • 1st Year Associate (76) $193
  • Analysts (235) $177
  • Intern/Summer Associate (29) $145
  • Junior Trader (5) $102
  • Intern/Summer Analyst (276) $95
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
dosk17's picture
dosk17
98.9
6
GameTheory's picture
GameTheory
98.9
7
DrApeman's picture
DrApeman
98.9
8
Betsy Massar's picture
Betsy Massar
98.9
9
CompBanker's picture
CompBanker
98.9
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”